tibolone has been researched along with Epithelial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Pan, L; Shen, K; Wen, Y; Wu, M | 1 |
| Lee, JM; Lee, KB; Park, CY; Yoon, JH | 1 |
2 other study(ies) available for tibolone and Epithelial Neoplasms
| Article | Year |
|---|---|
The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
Topics: Adolescent; Adult; Carcinoma, Ovarian Epithelial; Case-Control Studies; China; Disease-Free Survival; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Hormone Replacement Therapy; Humans; Kaplan-Meier Estimate; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Postoperative Period; Proportional Hazards Models; Retrospective Studies; Survival Rate; Young Adult | 2013 |
The safety of tibolone in epithelial ovarian cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Case-Control Studies; Chi-Square Distribution; Climacteric; Disease-Free Survival; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2006 |